Not available outside of the UK & Ireland.
Application
Lisinopril has been used to study the antifibrotic effect in duchenne muscular dystrophy mice. It has been used to study the changes in renal-structure and -function in TGR(mRen2)27 (transgenic rat harboring the murine Ren-2 gene) rats upon long term darbepoetin α treatment.
Biochem/physiol Actions
Angiotensin converting enzyme (ACE) inhibitor.
Features and Benefits
This compound was developed by Merck & Co., Inc., Kenilworth, NJ, U.S.. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Packaging
100, 250 mg in glass bottle
This product has met the following criteria: